The CUSP9v3 Clinical Trial To Fight Glioblastoma

The CUSP9v3 Clinical Trial To Fight Glioblastoma

The second conference organized by Glioblastoma.IT ODV was also very successful and almost 400 people have watched it in just 8 days. The inaugural conference was seen by over 800 people in just one month. New videoconferences are already in preparation for 2022 but before the end of the year, Glioblastoma.IT ODV is organizing a conference entitled “The CUSP9v3 Clinical Trial”. The event will take place on Tuesday 14 December from 17:30 to 19:00 and this time will take place in English with translation into Italian, again via videoconference on the Zoom platform. The event will be attended by the internationally renowned expert leading the study: Prof. Dr. med. Marc-Eric Halatsch, specialist in oncological and spinal neurosurgery and Chief Consultant Neurosurgeon of the Neurosurgery Clinic of the Cantonal Hospital of Winterthur in Switzerland.

Prof. Halatsch will describe the protocol and the results obtained so far with the CUSP9v3 protocol which simultaneously uses 9 drugs to fight glioblastoma. This approach originates from the approach followed by Ben Williams, author of the book Surviving “Terminal” Cancer and of the guide Treatment Options for Glioblastoma Multiforme and other High Grade Gliomas.

The event will open with a very short presentation of the voluntary organization Glioblastoma.IT ODV, will follow the talk of the speaker and will end as usual with a session open to participants dedicated to questions and answers from the experts.


TUESDAY 14 DECEMBER 2021 AT 5.30 pm – 7.00 pm


17:30-17:40 Dott. Roberto Pugliese – Introduction to the works


18:20-18:50 Questions and Answers

18:50-19:00 Dott. Roberto Pugliese – Conclusion of the works

Two platforms will be used for the event: Zoom and YouTube. The event will also be recorded to be available and accessible even to those who cannot participate. Links to the zoom event to participate and the youtube channel to follow the event in streaming are shown below.

Link to the videoconference on the Zoom platform: >>> Zoom Link. <<<

Link to the streaming and recording of the video conference on YouTube: >>> YouTube channel. <<<

This is the third of our events dedicated to glioblastoma. As you remember, the CUSP9v3 Phase II-III clinical trial is the subject of the fundraising campaign that the voluntary organization Glioblastoma.IT ODV has been pushing for some time through various channels, including the fundraising campaign “CUSP-ND: trial to beat the Glioblastoma in memory of Emanuele “. We hope many of you will join us.